SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-24-113912
Filing Date
2024-04-25
Accepted
2024-04-25 16:14:58
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-25

Document Format Files

Seq Description Document Type Size
1 ARS d769887dars.pdf ARS 9012651
  Complete submission text file 0001193125-24-113912.txt   12414220
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38096 | Film No.: 24876476
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)